October 25, 2026 03:38 am (IST)

Make this your homepage

All Finance

Jamia shifts classes online after clash over demand for student union polls; Congress MPs face allegations | Deadly mid-air collision: Four pilots killed as two military aircraft crash in Philippines | ‘Jihad’ calls, Modi assassination remarks: Mumbai Rapido driver arrested over alleged Jaish links | Vegetarian-only kitchen at Keralam Lok Bhavan? Governor's reported order triggers political backlash | ‘Another little Epic Fury’: Trump’s chilling warning to Iran as fresh US strikes loom | Bomb threat email names Amitabh Bachchan’s Jalsa bungalow, Diljit Dosanjh’s concert venue: Reports | ‘Face-offs still continue’: ITBP chief reveals fresh India-China border tensions in Arunachal | Eiffel Tower women staff row: BAPS monk blames ‘miscommunication’, denies delegation's role | ‘Pen, not stones and guns’: RSS-linked group opens its first office in Kashmir Valley under Muslim leader | First human case of Shamonda virus reported in France; WHO confirms death of immunocompromised patient

GlaxoSmithKline records 8% growth

India Blooms News Service | | Aug 07, 2014, at 04:03 am

New Delhi, Aug 6 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the first quarter ended June 30, 2014, where it recorded its net sales at Rs 922 crores, making a growth of 8% over 2013 with PAT at Rs. 130 crores growing by 9% for the same period and PBT at Rs 198 crores growing by 9%.

Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are proud to deliver consistent growth ahead of the category. This is significant in a scenario where consumption pattern is being impacted by inflation. Our sciences based products with its superior value, continue to remain relevant for our large consumer base."

"As a market leader we are also growing the category with successful launches of new products which are driving up consumption experiences. Our focused access strategy ensures that consumption and penetration has been the enabler for growth. Customer driven innovations and clutter breaking marketing based on sharp consumer insights will continue to be our driving force in the coming months to bring in more consumers closer to the product," he said.

The company also noted that in a recent addition to the Board of Directors, Sangeeta Talwar has been appointed as an Independent Director in casual vacancy created by the resignation of Ireena Vittal.

#GlaxoSmithKline records 8% growth

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.

India
International

Related Images

In Images: Gautam Adani offers prayers at Kalighat Temple in Kolkata Sep 24, 2026, at 11:48 am

In Images: Amit Shah performs 'Bhoomi Pujan' of Amul's curd manufacturing plant in Kolkata Jul 19, 2026, at 10:57 pm

Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:41 pm